Paul Riley is a British Heart Foundation Professor of Regenerative Medicine based at the University of Oxford. He is also Director of the BHF Oxbridge Centre for Regenerative Medicine and inaugural Director of the Institute of Developmental and Regenerative Medicine which will come online in early 2022. He was formerly Professor of Molecular Cardiology at the UCL-Institute of Child Health, London, where he was a principal investigator within the Molecular Medicine Unit for 12 years. Prior to this, he obtained his PhD at UCL and completed post-doctoral fellowships in Toronto and Oxford. In 2008, Professor Riley was awarded an Outstanding Achievement Award by the European Society of Cardiology, in recognition of his team’s discovery that activated epicardial cells can regenerate the adult mammalian heart, and in 2014 he was elected a fellow of the Academy of Medical Sciences.